shRNA-mediated knockdown of SETD2 led to proliferative advantage, increased colony formation and accelerated leukemia development of fusion-protein expressing leukemia cells in vitro and in vivo, further establishing a tumor suppressive role of SETD2 in leukemia. Here, SETD2 is linked to leukemia.